Were There Any Significant Reasons Why The HeartBeam (BEAT) Stock Increased 19% Pre-Hours?

The shares of HeartBeam Inc. (NASDAQ: BEAT) soared 19.62% in premarket trading to $1.89 at the last check. In the absence of any significant news, the stock’s price is surging to recover the loss it suffered in the previous session. Wednesday’s session ended with BEAT stock down -16.40% at $1.58.


Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.

Sponsored


BEAT is recovering because of what?

HeartBeam (BEAT) is showing signs of recovery as the company has released a new video that takes viewers behind the scenes to highlight its AIMIGo technology, which will be shown during the webcast.

  • The video was released during a virtual roadshow webinar on September 20, 2022, by the cardiac technology company.
  • The video explored the technology behind HeartBeam AIMIGo, the market potential, and the use of the device in the detection of heart attacks.
  • The AIMIGo is the first and only 12-lead output ECG device that has a 510(K) regulatory pathway for remote heart attack detection.
  • The US Food and Drug Administration (FDA) expects BEAT to submit AIMIGo for approval by the end of the year.
  • AMIGo, once cleared, could allow patients and their doctors to determine whether symptoms are caused by a heart attack, quickly and easily, so that appropriate care can be initiated.
  • With BEAT technology, triage patients can be treated more quickly, and healthcare dollars can be saved.
  • A new video highlighting the capabilities of BEAT’s AIMIGo device for remote heart attack detection was released as part of a compelling overview and explanation of our technology.
  • In addition to the video, HeartBeam also shared recent announcements, ongoing initiatives, and key milestones for 2022 and 2023 at its webinar.

BEAT’s webinar was presented by whom?

CEO and founder of HeartBeam (BEAT), Branislav Vajdic, Ph.D., Chief Financial Officer Rick Brounstein, and Chief Business Officer Jon Hunt, Ph.D., hosted a virtual roadshow webinar during which they discussed recent announcements, including HeartBeam AIMI’s 510(k) application to the FDA and the recently issued patent for a 12-lead electrocardiogram (ECG) patch monitor, as well as ongoing initiatives and key milestones for 2022 and 2023. The FDA has not yet approved BEAT AIMI and AIMIGo for marketing in the USA or other countries.

Latest

On What Basis Did Swvl Holdings Corp (SWVL) Stock Rise 47% Pre-Hours?

When last checked, Swvl Holdings Corp. (Nasdaq: SWVL), a...

What Drove Organovo (ONVO) Stock Up 15% In After-Hour Session On Tuesday?

Shares of Organovo Holdings Inc. (Nasdaq: ONVO) were up...

Is There Any Reason As To Why The Zai Lab (ZLAB) Stock Expanded By 13%?

The biopharmaceutical business Zai Lab Limited (NASDAQ: ZLAB), which...

Newsletter

 

Don't miss

Did Anything Boost ObsEva (OBSV) Stock In Pre-Hours Trading?

Following an update, shares of ObsEva SA (NASD: OBSV)...

How Did The Kalera (KAL) Stock Rise 32% Pre-Hours?

At the time of the most recent check, shares...

Why Has Selina Hospitality (SLNA) Stock Increased In Extended Session On Friday?

The stock of Selina Hospitality PLC (NASD: SLNA), which...

Do You Know Why Evolv Technologies (EVLV) Stock Surged Nearly 10% Today?

Today's charts show Evolv Technologies Holdings Inc. (Nasdaq: EVLV)...

5 Best TaaS Stocks to Buy Right Now

TaaS stock refers to a financial asset sold by...

Inpixon (INPX) average volume reaches $1.32M: Is Wall Street expecting a rally?

Inpixon (NASDAQ: INPX) on January 27, 2023, started off the session at the price of $1.38, plunging -20.55% from the previous trading day. During...

Investors must take note of Proterra Inc.’s (PTRA) performance last week, which was 2.02%.

January 27, 2023, Proterra Inc. (NASDAQ: PTRA) trading session started at the price of $4.78, that was 4.76% jump from the session before. During...

Ideanomics Inc. (IDEX) with a beta value of 0.60 appears to be a promising investment opportunity.

On January 27, 2023, Ideanomics Inc. (NASDAQ: IDEX) opened at $0.1897, higher 7.56% from the last session. During the day, the shares moved up...

LEAVE A REPLY

Please enter your comment!
Please enter your name here